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Abstract
Background: Eosinophilic meningitis (EOM) is a rare condition that is caused by various communicable and non-
communicable factors. The rat-lungworm Angiostrongylus cantonensis, which is associated with consumption of raw
or undercooked paratenic or intermediate hosts, is the most common cause of parasitic eosinophilic meningitis
worldwide. While the majority of A. cantonensis cases are reported from endemic regions, cases in travelers pose a
challenge to clinicians in non-endemic countries. Here we report a rare case of eosinophilic meningitis caused by A.
cantonensis in a Swiss traveler who was diagnosed after returning from Thailand.
Case presentation: A 33-year old woman with a travel history to rural north-eastern Thailand presented to an
emergency department in Switzerland with severe headache and vomiting. Eosinophilic meningitis was confirmed
as the cause of the symptoms; however, serologic investigations failed to confirm an A. cantonensis infection on the first
evaluation. Nevertheless, empirical treatment with an anthelminthic and steroid regimen led to a rapid alleviation of
symptoms. Repeated serology confirmed seroconversion 2 weeks after treatment initiation.
Discussion: Parasitic etiology must be considered in returning travelers who present with symptoms compatible with a
central nervous system infection. A thorough medical history, including types of food consumed, is paramount and can
often suggest differential diagnosis. Neuroangiostrongyliasis is rare and might be missed if serology does not cover
possible seroconversion.
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Background
Parasitic central nervous system (CNS) infections are ex-
pected to become more common in non-endemic coun-
tries. Parasitic etiologies require more consideration in
travelers presenting with symptoms suggestive of a CNS in-
fection. Overlapping and often non-specific clinical symp-
toms in combination with their scarcity and epidemiologic
peculiarities make parasitic CNS infections a diagnostic
challenge [1]. The rat-lungworm Angiostrongylus cantonen-
sis is the most common cause of parasitic eosinophilic
meningitis (EOM) worldwide [2]. Infective third-stage
Angiostrongylus larvae are found in intermediate hosts (i.e.
gastropods such as snails or slugs), food products contami-
nated with gastropods or gastropod mucus (e.g. vegetables,
fruits) or in paratenic hosts (e.g. shrimp, prawns, crabs,
monitor lizards, frogs, mussels). Accidental or deliberate in-
gestion of raw or undercooked food products containing
the neurotropic third-stage larvae causes CNS infections in
humans [3]. Larvae pass the gastrointestinal tract, actively
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cross into systemic circulation and migrate to the central
nervous system. Symptoms occur after an incubation
period that varies from 7 to 35 days [3].
A. cantonensis cases are primarily reported from en-
demic regions (Fig. 1) [4]. However, due to an increase in
international travel, individual tourism, and a change in
risk behavior, an increment in sporadic cases of A. canto-
nensis in non-endemic countries is expected [5]. The rare
occurrence and usually self-limiting course of the disease
are 2 factors that contribute to the assumption that many
cases of A. cantonensis remain undiagnosed.
Here we present a rare case of an EOM caused by A.
cantonensis in a visiting friends and relatives (VFR)
traveler.
The case
In August 2018 a 33-year old woman presented with a
history of progressive headache, nausea and vomiting.
The patient is of Thai origin but has resided in
Switzerland for 6 years. However, she regularly travels to
rural north-eastern Thailand, which was also the case
prior to onset of symptoms. Two weeks after arrival in
Thailand, the patient noted self-limiting diarrhea that
was followed by non-specific symptoms (i.e. fatigue, feel-
ing of generalized swelling, leg accentuated weakness).
Two weeks after onset of these non-specific symptoms
the patient returned to Switzerland and reported symp-
tom aggravation in the form of gradually increasing
headache. The initial headache location shifted from the
right to the left hemisphere and eventually manifested as
holocranial headache of dull-throbbing character. The
patient, who denied being prone to headaches, described
severe headache (numerical rating scale 7–10) that was
not responsive to nonsteroidal anti-inflammatory drugs.
Insomnia due to persistence of headache with additional
occurrence of nausea and vomiting prompted the patient
to attend the emergency department 5 days after return-
ing from Thailand.
On admission, the patient was afebrile (temperature
36,8 °C), fully conscious (Glasgow Coma Scale 15) and
without focal neurologic deficits or signs of meningism.
The medical history revealed a pre-existing, inactive
hepatitis B infection and subclinical hypothyroidism. For
both conditions no treatment was taken at the time of
presentation. From routine screening during a previous
pregnancy, HIV was known the be negative. A complete
blood count (CBC), clinical chemistry, a lumbar punc-
ture (LP) and cranial computed tomography (CT) was
ordered. The CBC indicated a neutrophil predominance
and biochemistry results were unremarkable. In the
Fig. 1 Geographical distribution of cerebral angiostrongyliasis. Legend: Map created by Rosalie Zimmermann, adapted from Wang QP et al.
Lancet Infect Dis 2008;8:621–630 and Barratt J et al. Parasitology 2016;143:1087–1118
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cerebrospinal fluid (CSF) eosinophilia was noted
(Table 1), a finding that was not reflected in the periph-
eral differential count.
A vascular occlusion in the supply area of the right
middle cerebral artery compatible with Moyamoya dis-
ease was suspected in the CT scan. Magnetic resonance
imaging (MRI) was performed, revealing adequate collat-
eral circulation and no evidence for a recent occlusion
or active vasculitis. A few age-appropriate non-specific
white-matter lesions were seen in both hemispheres but
no leptomeningeal nor nodular enhancing lesions.
The pleocytosis (cell count of 1067/μL) in the CSF,
and the abnormally elevated absolute and relative eo-
sinophil counts of 267/μL and 25% respectively, led to
the diagnosis of EOM (Fig. 2). Considering the travel
history, an empirical treatment with albendazole (400
mg, BD) and prednisolone (60 mg OD) was started to
cover parasitic EOM. Additionally, serological testing for
tissue helminths was ordered and performed at the
national reference center at Swiss Tropical and Public
Health Institute, Basel, Switzerland alongside other
neurotropic pathogens.
Enzyme-linked electroimmunotransfer blot (EITB) for
A. cantonensis and Gnathostoma spp specific IgG anti-
bodies performed with serum were nonreactive. IgG
screening ELISAs and IgG/IgM/IgA indirect fluorescent
antibody tests for Echinococcus granulosus, Fasciola spp.,
Filaria spp. Schistosoma spp., Strongyloides stercoralis,
Trichinella spp and Toxocara spp. as well as screening
for other neurotropic pathogens (i.e. Borrelia burgdor-
feri, Tick-borne encephalitis virus, Treponema pallidum)
and HIV were negative. Aside from the afore-mentioned
pathogens, the origin of symptoms due to an infection
with free living amoeba (FLA) was considered. However,
since neither typical features of primary amoebic menin-
goencephalitis (caused by Naegleria) nor granulomatous
amoebic encephalitis (caused by Acanthamoeba) were
seen, no molecular or immunologic tests to rule out a
FLA infection were requested.
As acute phase Angiostrongylus serology can be nega-
tive, the empirical treatment was continued and follow
up serology was recommended. The dual anthelminthic
and anti-inflammatory therapy led to a marked clinical
improvement, and the patient was discharged home after
6 days of hospitalization.
Two weeks after treatment initiation, the patient was
seen for a follow up visit in the outpatient department.
At this visit, no more symptoms were reported and sero-
logic testing for A. cantonensis and Gnathostoma spp,
the two most likely causes of the initial symptoms were
repeated. While the latter remained negative, the sero-
logical test for A. cantonensis turned positive, indicating
Table 1 Cerebrospinal fluid and blood results
Test (Unit) Result Reference Rangea
Cerebrospinal fluid
• Appearance Cloudy Clear
• Xanthochromia Negative Negative
• Erythrocytes (× 1012/L) 0 0
• Cell count (× 109/L) 1067 0–3
• Lymphocytes (%) 56
• Monocytes (%) 19
• Eosinophils (%) 25 ‡
• Total protein (g/L) 0.54 0.15–0.45
• Albumin (g/L) 0.299 0.06–0.24
• Glucose (mmol/L) 2.6 2.2–3.9
• Lactate (mmol/L) 1.8 1.2–3.9
Complete Blood Count
• Leukocytes (×109/L) 6.5 2.6–7.8
o Neutrophils (× 109/L) 6.21 0.9–4.5
o Banded neutrophils (×109/L) 0.04 0.0–0.2
o Eosinophils (×109/L) 0.01 0.0–0.4
o Basophils (×109/L) 0.01 0.0–0.05
o Monocytes (×109/L) 0.05 0.0–1.0
o Lymphocytes (×109/L) 0.79 1.0–3.0
• Erythrocytes (×1012/L) 4.16 3.7–5.0
• Hemoglobin (g/L) 117 115–148
• Hematocrit 0.35 0.34–0.43
• Platelet (×109/L) 193 130–330
• C reactive protein (mg/L) < 5 < 5
Abnormal results are shown in bold
aReference ranges according to the hospital laboratory
‡Eosinophilic meningitis is defined as 10 or more eosinophils/μL or
eosinophilia of at least 10% of the total CSF leukocyte count [8]
Fig. 2 Cerebrospinal fluid smear of our patient. Legend:
Pappenheim (May-Grünwald-Giemsa) stain, magnification × 60. Black
arrows indicate eosinophil granulocytes with mostly bilobed,
occasionally trilobed nucleus and normal eosinophilic granulation
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seroconversion and, thus confirming the Angiostrongylu-
s-associated EOM. Recommended treatment with alben-
dazole (3 weeks) and prednisolone (2 weeks) was
completed and the patient recovered completely.
Discussion
Human health and travelers’ health in particular is
strongly influenced by altering interrelationships between
international travel, globalization of trade and agriculture,
migration as well as food production in a “warming world”
[6]. In addition, ripple effects of adventure travel, exotic
eating habits and exotic pet trade have repercussions on
the epidemiology of communicable diseases that are trad-
itionally considered tropical diseases [6].
In parasitic CNS infections, signs and symptoms are
often non-specific and/or overlapping making clinical diag-
nosis arduous. Travelers returning from potentially en-
demic countries complaining about severe headache should
be generously evaluated for parasitic CNS infections. A
thorough travel history and assessment of risk behavior
while traveling can guide diagnosis and direct further diag-
nostic measures. This patient ingested uncooked freshwater
mussels from a lake in rural north-eastern Thailand 20 days
before the headache commenced.
Magnetic resonance imaging is the radiologic method
of choice if parasitic CNS infections are suspected [7].
However, findings in neuroimaging studies have their
limitations and also did not contribute significantly to
the confirmation of the diagnosis in this patient.
Confirmatory diagnosis is based on laboratory methods
[1]. CSF investigations are paramount in the workup if
meningitis is suspected to confirm EOM (i.e. an eosinophil
count of ≥10 eosinophils per microliter, or eosinophilia of
≥10% of the total CSF leukocyte count [8]). Various para-
sitic causes of EOM have to be considered and ruled out
where applicable (Fig. 3). CSF xanthochromia is an indica-
tor for the distinction between A. cantonensis and
Gnathostomiasis as it is suggestive of the latter [9]. Absent
xanthochromia led to presumptive diagnosis of A. canto-
nensis in the presented case and guided the decision-mak-
ing process for empirical treatment.
Most cases manifest symptoms in the first 1–2weeks
after larva ingestion. However, incubation periods of
months [10] and autochthonous A. cantonensis cases from
non-endemic areas have been reported [11, 12]. EOM or
meningoencephalitis are the most common manifestations
followed by ocular angiostrongyliasis [5, 13]. The cardinal
symptom in EOM is headache and affects up to 95% of
cases [3]. Vasodilatation in the subarachnoid space resulting
Fig. 3 Predominant symptoms in parasitic CNS infections. Legend: Adapted from Carpio et al., Expert Rev. Neurother. 2016;16 (4):401–4,142,016
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from widespread inflammatory reaction in the meninges
and decreased resorption of CSF lead to increased intracra-
nial pressure, explaining other neurologic findings (e.g.
neck stiffness, paresthesia, cerebral nerve palsy, nausea and
vomiting) associated with neuroangiostrongyliasis [9, 14].
Since larva recovery from CSF is rare, confirmation is
mainly based on detection of antibodies in serum or
CSF. Unfortunately, there was not enough residual CSF
to perform serologic tests in the patient presented here.
Detection of A. cantonensis DNA by polymerase chain
reaction in the CSF has been described, but is only avail-
able in specialized laboratories [2]. As demonstrated in
this case, false negative results are possible if serologic
testing is restricted to single admission samples (imped-
ing documented seroconversion). Paired serologic testing
in weekly time intervals increases diagnostic detection as
seroconversion can be rare: only 2 cases of documented
seroconversion in human neuroangiostrongyliasis were
identified in a systematic literature search [12, 15].
The course of disease is determined by the parasite’s
biology in the human host. Humans are considered
dead-end hosts as the larvae cannot develop to adult
worms and die after completed migration to the CNS.
This explains the self-limiting course of disease [3, 5]
and why most infections are mild. However, prolonged
and severe courses as well as fatal cases have been re-
ported [16, 17]. Repeated lumbar punctures are an ef-
fective means to relieve headaches by reducing
intracranial pressure [9]. Administration of steroids can
reduce frequency of lumbar punctures, duration of head-
ache and analgesics use [18]. Anthelmintic drugs are ef-
fective against early larval stages [19] and may reduce
duration of headache [20]. However, their role in the
treatment of neuroangiostrongyliasis remains controver-
sial as they potentially exacerbate neurological symp-
toms via inducing host immune-inflammatory responses
[3, 21]. Consequently, the recommended treatment regi-
mens for A. cantonensis are still debated. Some studies
found that combinations of antihelminths and steroids
are effective [22–24] or at least not inferior and safe [25]
in the treatment of EOM caused by A. cantonensis. In
our case, a combination of albendazole with prednisol-
one was effective and resulted in a complete recovery.
Conclusion
Ecological, biological and economic changes can exert their
effects on the epidemiology of communicable diseases.
Health care providers are increasingly confronted with
“exotic” diseases in a merging and globalized world. Even
though EOM is rare, preemptive treatment with subsequent
follow-up serology is advised if neuroangiostrongyliasis is
suspected. Early diagnosis and appropriate management re-
sults in favorable outcomes in the majority of cases.
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